Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Facebook
Twitter
Pinterest
Telegram
Linkedin
WhatsApp
Artículos Relacionados
Comentarios
Deja un comentario
Todos los campos son requeridos
Más Vistas
- Presidente cubano ratificó su apoyo solidario a mandataria mexicana
- Producción de harina de trigo se estabiliza en molinos cubanos (+Video)
- Firman en Cambodia acuerdo para impulsar producción de arroz en Cuba
- Distribuyen en Cuba kit de evaluación sanitaria para adultos mayores
- Vallista corto Yander Herrera matiza inicio del Memorial Molina de Atletismo
